Cargando…

HNF4G increases cisplatin resistance in lung adenocarcinoma via the MAPK6/Akt pathway

BACKGROUND: Lung adenocarcinoma is one of the most common tumors, and cisplatin is frequently used in treating lung adenocarcinoma patients. This study aimed to look into the roles and mechanisms of HNF4G in cisplatin resistance of lung adenocarcinoma. MATERIALS & METHODS: Cisplatin resistance a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liang, Jiaqi, Zhao, Guangyin, Bian, Yunyi, Bi, Guoshu, Sui, Qihai, Zhang, Huan, Shi, Haochun, Shan, Guangyao, Huang, Yiwei, Chen, Zhencong, Wang, Lin, Zhan, Cheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	PeerJ Inc. 2023
Materias:	Biochemistry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10010171/ https://www.ncbi.nlm.nih.gov/pubmed/36923501 http://dx.doi.org/10.7717/peerj.14996

Ejemplares similares

Hepatic nuclear factor 4 alpha promotes the ferroptosis of lung adenocarcinoma via transcriptional activation of cytochrome P450 oxidoreductase
por: Besskaya, Valeria, et al.
Publicado: (2023)

Signatures of malignant cells and novel therapeutic targets revealed by single‐cell sequencing in lung adenocarcinoma
por: Liang, Jiaqi, et al.
Publicado: (2022)

Cisplatin resistance-related multi-omics differences and the establishment of machine learning models
por: Sui, Qihai, et al.
Publicado: (2022)

Identification of the relationship between single-cell N6-methyladenosine regulators and the infiltrating immune cells in esophageal carcinoma
por: Bian, Yunyi, et al.
Publicado: (2023)

Characterization of Infiltrating Immune Cells and Secretory or Membrane-Associated Proteins in KRAS Lung Adenocarcinoma
por: Bian, Yunyi, et al.
Publicado: (2023)

Genetic and microenvironmental differences in non-smoking lung adenocarcinoma patients compared with smoking patients
por: Sui, Qihai, et al.
Publicado: (2020)

miR-6077 promotes cisplatin/pemetrexed resistance in lung adenocarcinoma via CDKN1A/cell cycle arrest and KEAP1/ferroptosis pathways
por: Bi, Guoshu, et al.
Publicado: (2022)

Integrated analysis of patients with KEAP1/NFE2L2/CUL3 mutations in lung adenocarcinomas
por: Jin, Xing, et al.
Publicado: (2021)

A nomogram to predict prognosis of patients with lung adenosquamous carcinoma: a population-based study
por: Liang, Jiaqi, et al.
Publicado: (2020)

Inhibition of PKA/CREB1 pathway confers sensitivity to ferroptosis in non-small cell lung cancer
por: Shan, Guangyao, et al.
Publicado: (2023)

Identification and Validation of a Proliferation-Associated Score Model Predicting Survival in Lung Adenocarcinomas
por: Bian, Yunyi, et al.
Publicado: (2021)

Clinicopathological and prognostic implications of ALK rearrangement in patients with completely surgically resected lung adenocarcinoma
por: Zhang, Huan, et al.
Publicado: (2021)

The genomic signature of resistance to platinum-containing neoadjuvant therapy based on single-cell data
por: Sui, Qihai, et al.
Publicado: (2023)

Correction to: The genomic signature of resistance to platinum-containing neoadjuvant therapy based on single-cell data
por: Sui, Qihai, et al.
Publicado: (2023)

The clinical prognostic factors of patients with stage IB lung adenocarcinoma
por: Sui, Qihai, et al.
Publicado: (2021)

Ligand-receptor interaction atlas within and between tumor cells and T cells in lung adenocarcinoma
por: Chen, Zhencong, et al.
Publicado: (2020)

KLF11 regulates lung adenocarcinoma ferroptosis and chemosensitivity by suppressing GPX4
por: Zhao, Guangyin, et al.
Publicado: (2023)

Knockdown of GTF2E2 inhibits the growth and progression of lung adenocarcinoma via RPS4X in vitro and in vivo
por: Bi, Guoshu, et al.
Publicado: (2021)

Long-term outcomes following neoadjuvant or adjuvant chemoradiotherapy for stage I–IIIA non-small cell lung cancer: a propensity-matched analysis
por: Xi, Junjie, et al.
Publicado: (2020)

Identification and analysis of a prognostic ferroptosis and iron-metabolism signature for esophageal squamous cell carcinoma
por: Zhao, Mengnan, et al.
Publicado: (2022)

Genomic And Tumor Microenvironment Differences Between Cell Cycle Progression Pathway Altered/Non-Altered Patients With Lung Adenocarcinoma
por: Shan, Guangyao, et al.
Publicado: (2022)

Tumor-Associated Regulatory T Cells in Non-Small-Cell Lung Cancer: Current Advances and Future Perspectives
por: Liang, Jiaqi, et al.
Publicado: (2022)

FGF19 promotes cell autophagy and cisplatin chemoresistance by activating MAPK signaling in ovarian cancer
por: Zhu, Wei, et al.
Publicado: (2023)

Multi-Omics Analysis of Cancer Cell Lines with High/Low Ferroptosis Scores and Development of a Ferroptosis-Related Model for Multiple Cancer Types
por: Shan, Guangyao, et al.
Publicado: (2021)

Analysis of the differences in lung cancer research trends between China and the United States based using project funding data
por: Zheng, Yuansheng, et al.
Publicado: (2021)

Dissecting the single-cell transcriptome network of macrophage and identifies a signature to predict prognosis in lung adenocarcinoma
por: Hu, Zhengyang, et al.
Publicado: (2023)

LncRNA FAM83A-AS1 facilitates tumor proliferation and the migration via the HIF-1α/ glycolysis axis in lung adenocarcinoma
por: Chen, Zhencong, et al.
Publicado: (2022)

Identification and validation of the mitochondrial function related hub genes by unsupervised machine learning and multi-omics analyses in lung adenocarcinoma
por: Jin, Xing, et al.
Publicado: (2022)

Compare the efficacy and safety of programmed cell death-1 (PD-1) and programmed cell death ligand-1 (PD-L1) inhibitors for advanced non-small cell lung cancer: a Bayesian analysis
por: Liang, Jiaqi, et al.
Publicado: (2020)

Cisplatin-resistant HepG2 cell-derived exosomes transfer cisplatin resistance to cisplatin-sensitive cells in HCC
por: Tang, Zuxiong, et al.
Publicado: (2021)

Landscape and dynamics of single tumor and immune cells in early and advanced‐stage lung adenocarcinoma
por: Chen, Zhencong, et al.
Publicado: (2021)

Dissecting the single-cell transcriptome network in patients with esophageal squamous cell carcinoma receiving operative paclitaxel plus platinum chemotherapy
por: Chen, Zhencong, et al.
Publicado: (2021)

C1orf74 positively regulates the EGFR/AKT/mTORC1 signaling in lung adenocarcinoma cells
por: Guo, Jinyong, et al.
Publicado: (2022)

Single-cell transcriptome atlas of lung adenocarcinoma featured with ground glass nodules
por: Lu, Tao, et al.
Publicado: (2020)

TAF4, a subunit of transcription factor II D, directs promoter occupancy of nuclear receptor HNF4A during post-natal hepatocyte differentiation
por: Alpern, Daniil, et al.
Publicado: (2014)

Enlarged Mediastinal Lymph Nodes in Computed Tomography are a Valuable Prognostic Factor in Non-Small Cell Lung Cancer Patients with Pathologically Negative Lymph Nodes
por: Zheng, Yuansheng, et al.
Publicado: (2020)

Pan-cancer characterization of metabolism-related biomarkers identifies potential therapeutic targets
por: Bi, Guoshu, et al.
Publicado: (2021)

Involvement of TOB1 on autophagy in gastric cancer AGS cells via decreasing the activation of AKT/mTOR signaling pathway
por: Wang, Dong, et al.
Publicado: (2022)

Detection of phosphorylated Akt and MAPK in cell culture assays
por: Molgaard, Simon, et al.
Publicado: (2016)

Aspirin inhibits tumor progression and enhances cisplatin sensitivity in epithelial ovarian cancer
por: Guo, Jianfeng, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3feokl50kitu6idv7rh1j5692j